BETA CEO files Form 4 for 30,000-share sale
BETA Technologies CEO Kyle Clark reported selling 30,000 shares between Oct. 7 and Oct. 9 at $20.41 apiece, according to a Form 4 filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
8 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Illumina Reports Q2 2026 Results: Full Earnings Call Transcript
On Thursday, Illumina (NASDAQ: ILMN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Illumina reported strong Q2 2026 performance with revenue gr
GRAIL Q2 2026 Earnings Call: Complete Transcript
On Wednesday, GRAIL (NASDAQ: GRAL ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary GRAIL reported a strong second quarter 2026
Full Transcript: Vale Q2 2026 Earnings Call
Vale (NYSE: VALE ) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Vale S.A. reported a strong Q2 2026 performance, with a 19% incre
D2L reports $55.6 million Q2 revenue, raises growth outlook
D2L said second-quarter revenue rose 2% to $55.6 million and annual recurring revenue increased 5% to $223.4 million. Management also cited U.S. K-12 churn, revised full-year revenue growth guidance lower and left EBITDA guidance unchanged.
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness
The U.S. Food and Drug Administration (FDA) on Monday named seven companies selected for its FDA PreCheck Pilot Program. The initiative aims at strengthening domestic pharmaceutical manufacturing, improving the resilience of the U.S. drug supply chain and providing companies with earlier regulatory engagement as they b
Kyle G files with SEC
Kyle Richard G submits filing to Securities and Exchange Commission
Kyle G files with SEC
Kyle Richard G submits filing to SEC, details not specified